VLBW: Type of Fat (2020)
-
Intervention
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on mortality?
-
Conclusion
One large RCT found no significant effect [relative risk of 1.31 (95%CI, 0.88 to 1.96)] on mortality in very low birthweight (VLBW) preterm infants receiving 60mg of DHA and 4mg of EPA per day, compared to placebo after approximately three months.
-
Grade: I
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on mortality?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on necrotizing enterocolitis?-
Conclusion
There was no significant effect (RR (95% CI) of 1.17 (0.80 to 1.71) on incidence of necrotizing enterocoloties (NEC) in very low birth weight preterm infants that received daily long chain omega-3 supplementation, with or without arachidonic acid (AA), for approximately 1-3 months compared to placebo.
-
Grade: I
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on necrotizing enterocolitis?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Collins C, Makrides M, McPhee A, Sullivan T, Davis P, Thio M, Simmer K, Rajadurai V, Travadi J, Berry M, Liley H, Opie G, Tan K, Lui K, Morris S, Stack J, Stark M, Chua M, Jayagobi P, Holberton J, Bolisetty S, Callander I, Harris D, Gibson R. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. The New England Journal of Medicine 2017; 376:1245-1255
- Innis S, Adamkin D, Hall R, Kalhan S, Lair C, Lim M, Stevens D, Twist P, Diersen-Schade D, Harris C, Merkel K, Hansen J. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. The Journal of Pediatrics 2002; 140:547-54
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on bronchopulmonary disease?-
Conclusion
Long chain omega-3 supplementation, provided as 60mg or less, in a marine oil fatty acid directly to the infant or through a lactating mother, for two to four months, did not significantly affect [RR of 0.85 (95% CI, 0.61 to 1.18)] incidence of bronchopulmonary disease. Heterogeneity of results was high (I2=79.61%), so these results should be interpreted with caution.
-
Grade: II
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on bronchopulmonary disease?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Carlson S, Werkman S, Tolley E. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. The American Journal of Clinical Nutrition 1996; 63:687-97
- Collins C, Makrides M, McPhee A, Sullivan T, Davis P, Thio M, Simmer K, Rajadurai V, Travadi J, Berry M, Liley H, Opie G, Tan K, Lui K, Morris S, Stack J, Stark M, Chua M, Jayagobi P, Holberton J, Bolisetty S, Callander I, Harris D, Gibson R. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. The New England Journal of Medicine 2017; 376:1245-1255
- Manley B, Makrides M, Collins C, McPhee A, Gibson R, Ryan P, Sullivan T, Davis P. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics 2011; 128:e71-7
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on retinopathy of prematurity?-
Conclusion
There was no significant effect of daily long-chain omega-3 supplementation, with or without arachidonic acid (AA), on retinopathy of prematurity (ROP) after one to three months of supplementation, compared to placebo, in very low birthweight (VLBW) preterm infants.
-
Grade: I
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on retinopathy of prematurity?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Collins C, Makrides M, McPhee A, Sullivan T, Davis P, Thio M, Simmer K, Rajadurai V, Travadi J, Berry M, Liley H, Opie G, Tan K, Lui K, Morris S, Stack J, Stark M, Chua M, Jayagobi P, Holberton J, Bolisetty S, Callander I, Harris D, Gibson R. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. The New England Journal of Medicine 2017; 376:1245-1255
- Innis S, Adamkin D, Hall R, Kalhan S, Lair C, Lim M, Stevens D, Twist P, Diersen-Schade D, Harris C, Merkel K, Hansen J. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. The Journal of Pediatrics 2002; 140:547-54
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on atopy (hay fever)?-
Conclusion
Supplementing lactating mothers with 500mg of DHA-rich capsules for nine weeks did not significantly affect risk of hay fever at 18 months of age (RR, 0.85; 95% CI, 0.23 to 3.13) in very low birthweight (VLBW) preterm infants.
-
Grade: III
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on atopy (hay fever)?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on neurodevelopment?-
Conclusion
Long-chain omega-3 supplementation for two to three months in very low birthweight (VLBW) preterm infants fed MOM did not have a significant effect (MD, 3.065; 95% CI, -0.988 to 7.118) on total Bayley II Mental Developmental Index or Ages and Stages Questionnaire score at 18 months to 20 months or full IQ score at seven years of age.
-
Grade: II
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on neurodevelopment
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Collins C, Gibson R, Anderson P, McPhee A, Sullivan T, Gould J, Ryan P, Doyle L, Davis P, McMichael J, French N, Colditz P, Simmer K, Morris S, Makrides M. Neurodevelopmental outcomes at 7 years corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial. BMJ Open 2015; 5:e007314
- Henriksen C, Haugholt K, Lindgren M, Aurvåg A, Rønnestad A, Grønn M, Solberg R, Moen A, Nakstad B, Berge R, Smith L, Iversen P, Drevon C. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008; 121:1137-45
- Makrides M, Gibson R, McPhee A, Collins C, Davis P, Doyle L, Simmer K, Colditz P, Morris S, Smithers L, Willson K, Ryan P. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. The Journal of the American Medical Association 2009; 301:175-82
- Westerberg A, Schei R, Henriksen C, Smith L, Veierød M, Drevon C, Iversen P. Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid. Acta Paediatrica 2011; 100:47-52
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on visual acuity?-
Conclusion
Long chain omega-3 supplementation at a daily level of 0.2-6.9% fatty acids as DHA, 0-0.3% EPA initially improved visual acuity compared to standard care in VLBW preterm infants. However, these benefits disappeared by 4 months corrected age. When 0.34% DHA was delivered with or without 0.60% AA for one month, there was no effect on visual acuity compared to standard care.
-
Grade: III
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of protein-energy via enteral nutrition on visual acuity?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Birch D, Birch E, Hoffman D ,Uauy R. Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Investigative Ophthalmology and Visual Science 1992; 33:2365-76
- Birch E, Birch D, Hoffman D, Uauy R. Dietary essential fatty acid supply and visual acuity development. Investigative Ophthalmology and Visual Science 1992; 33:3242-53
- Carlson S, Werkman S, Rhodes P, Tolley E. Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. The American Journal of Clinical Nutrition 1993; 58:35-42
- Carlson S, Werkman S, Tolley E. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. The American Journal of Clinical Nutrition 1996; 63:687-97
- Hoffman D, Birch E, Birch D, Uauy R. Effects of supplementation with omega 3 long-chain polyunsaturated fatty acids on retinal and cortical development in premature infants. The American Journal of Clinical Nutrition 1993; 57:807S-812S
- Innis S, Adamkin D, Hall R, Kalhan S, Lair C, Lim M, Stevens D, Twist P, Diersen-Schade D, Harris C, Merkel K, Hansen J. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. The Journal of Pediatrics 2002; 140:547-54
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on feeding tolerance?-
Conclusion
In one large RCT, daily supplementation of 64mg of long chain omega-3 for three months had no significant effect (MD, 0.1; 95% CI, 1.98 lower to 1.78 higher), compared to placebo, on days until full enteral feeds in very low birthweight (VLBW) preterm infants.
-
Grade: I
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of protein-energy via enteral nutrition on feeding tolerance?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on weight gain?-
Conclusion
Long-chain omega-3 supplementation (docosahexaenoic acid [DHA] or eicosapentaeonic acid [EPA]) in human milk did not significantly affect weight in very low birth weight (VLBW) infants, but the effect of supplementation in formula was mixed. While limited evidence suggested that formula with DHA may have no effect or may even decrease weight compared to controls, when arachidonic acid was added to DHA for 30 days, infant had significantly greater weight gain compared to controls at 57 weeks post-menstrual age.
-
Grade: III
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on weight gain?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Birch E, Birch D, Hoffman D, Uauy R. Dietary essential fatty acid supply and visual acuity development. Investigative Ophthalmology and Visual Science 1992; 33:3242-53
- Carlson S, Cooke R, Werkman S, Tolley E. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992; 27:901-7
- Carlson S, Werkman S, Tolley E. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. The American Journal of Clinical Nutrition 1996; 63:687-97
- Collins C, Makrides M, Gibson R, McPhee A, Davis P, Doyle L, Simmer K, Colditz P, Morris S, Sullivan T, Ryan P. Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trial. The British Journal of Nutrition 2011; 105:1635-43
- Henriksen C, Haugholt K, Lindgren M, Aurvåg A, Rønnestad A, Grønn M, Solberg R, Moen A, Nakstad B, Berge R, Smith L, Iversen P, Drevon C. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008; 121:1137-45
- Innis S, Adamkin D, Hall R, Kalhan S, Lair C, Lim M, Stevens D, Twist P, Diersen-Schade D, Harris C, Merkel K, Hansen J. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. The Journal of Pediatrics 2002; 140:547-54
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on length gain?-
Conclusion
Long chain omega 3 supplementation, with or without the addition of arachidonic acid, did not significantly affect length gain at term and up to 18 months of age in very low birthweight preterm infants receiving human milk or infant formula.
-
Grade: III
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on length gain?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Carlson S, Cooke R, Werkman S, Tolley E. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992; 27:901-7
- Carlson S, Werkman S, Tolley E. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. The American Journal of Clinical Nutrition 1996; 63:687-97
- Collins C, Makrides M, Gibson R, McPhee A, Davis P, Doyle L, Simmer K, Colditz P, Morris S, Sullivan T, Ryan P. Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trial. The British Journal of Nutrition 2011; 105:1635-43
- Henriksen C, Haugholt K, Lindgren M, Aurvåg A, Rønnestad A, Grønn M, Solberg R, Moen A, Nakstad B, Berge R, Smith L, Iversen P, Drevon C. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008; 121:1137-45
- Innis S, Adamkin D, Hall R, Kalhan S, Lair C, Lim M, Stevens D, Twist P, Diersen-Schade D, Harris C, Merkel K, Hansen J. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. The Journal of Pediatrics 2002; 140:547-54
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on head circumference?-
Conclusion
The effect of long chain omega-3 supplementation through human milk and formula on head circumference in very low birthweight preterm infants is unclear.
-
Grade: III
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on head circumference?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Carlson S, Cooke R, Werkman S, Tolley E. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992; 27:901-7
- Carlson S, Werkman S, Tolley E. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. The American Journal of Clinical Nutrition 1996; 63:687-97
- Collins C, Makrides M, Gibson R, McPhee A, Davis P, Doyle L, Simmer K, Colditz P, Morris S, Sullivan T, Ryan P. Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trial. The British Journal of Nutrition 2011; 105:1635-43
- Henriksen C, Haugholt K, Lindgren M, Aurvåg A, Rønnestad A, Grønn M, Solberg R, Moen A, Nakstad B, Berge R, Smith L, Iversen P, Drevon C. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008; 121:1137-45
- Innis S, Adamkin D, Hall R, Kalhan S, Lair C, Lim M, Stevens D, Twist P, Diersen-Schade D, Harris C, Merkel K, Hansen J. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. The Journal of Pediatrics 2002; 140:547-54
- Detail
-
Search Plan and Results: VLBW: Type of Fat (2019)
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on sepsis?-
Conclusion
There was no significant effect (RR (95% CI) of 0.94 (0.81, 1.10) on incidence of sepsis in very low birthweight preterm infants that received daily long-chain omega-3 supplementation, with or without arachidonic acid, for approximately 1-3 months, compared to placebo.
-
Grade: I
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on sepsis?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Collins C, Makrides M, McPhee A, Sullivan T, Davis P, Thio M, Simmer K, Rajadurai V, Travadi J, Berry M, Liley H, Opie G, Tan K, Lui K, Morris S, Stack J, Stark M, Chua M, Jayagobi P, Holberton J, Bolisetty S, Callander I, Harris D, Gibson R. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. The New England Journal of Medicine 2017; 376:1245-1255
- Innis S, Adamkin D, Hall R, Kalhan S, Lair C, Lim M, Stevens D, Twist P, Diersen-Schade D, Harris C, Merkel K, Hansen J. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. The Journal of Pediatrics 2002; 140:547-54
- Detail
In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of fat via enteral nutrition on adverse effects?-
Conclusion
Limited evidence suggests no difference in adverse events between long-chain omega-3, with or without arachidonic acid, and control supplements in very low birth weight (VLBW) preterm infants.
-
Grade: III
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
-
Evidence Summary: In VLBW preterm infants (less than or equal to 1,500g at birth), what is the effect of type of at via enteral nutrition on adverse effects?
- Detail
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- Worksheets
- Henriksen C, Haugholt K, Lindgren M, Aurvåg A, Rønnestad A, Grønn M, Solberg R, Moen A, Nakstad B, Berge R, Smith L, Iversen P, Drevon C. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008; 121:1137-45
- Innis S, Adamkin D, Hall R, Kalhan S, Lair C, Lim M, Stevens D, Twist P, Diersen-Schade D, Harris C, Merkel K, Hansen J. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. The Journal of Pediatrics 2002; 140:547-54
- Detail
-
Conclusion